CLASTOBAN® - Bioprojet
2121
portfolio_page-template-default,single,single-portfolio_page,postid-2121,bridge-core-2.9.3,,qode_grid_1200,footer_responsive_adv,qode-child-theme-ver-1.0.0,qode-theme-ver-27.7,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-6.7.0,vc_responsive
 

CLASTOBAN®

CLASTOBAN®

anhydrous sodium clodronate (film-coated tablet)

  • Oral follow-up treatment of injectable therapy for malignant hypercalcaemia
  • Palliative treatment of osteolysis of malignant origin with or without hypercalcaemia, in conjunction with specific cancer treatment

In the event of hypercalcaemia, the treatment must be associated with optimal rehydration.

Useful links

Public drug database
BASE-DONNEES-PUBLIQUE.MEDICAMENTS.GOUV.FR

French Healthcare Authority
has-sante.fr